1887
Volume 2022 Number 1
  • ISSN: 1999-7086
  • EISSN: 1999-7094

Abstract

: Mesaieed Hospital (MSH) was a COVID-19 center from the 7th of February till the 28th of June, 2021 with a high capacity and turnover. Therefore, timely discharge was crucial.1 Before implementing the clinical pharmacy service, MSH discharge pharmacy was receiving discharge prescriptions from noon. Since clinical pharmacists did not review discharge prescriptions, errors identified by the discharge pharmacy resulted in further delays in patients’ disposition to quarantine facilities.2,3

This project aimed to achieve a 100% clinical-pharmacist review of planned discharges before 15:00 by May 30, 2021 and decrease the time to bulk patients’ transfer to quarantine facilities to start from 16:00 instead of 19:00. : As early as 09:00, clinical pharmacists sent the reviewed discharges to the discharge pharmacy for discharge medication preparation through Microsoft-Teams. The clinical pharmacists reviewed and solved all drug-related issues before 15:00. In addition, the clinical pharmacists reviewed planned patient discharges without medication orders, and discharge plans were documented on Cerner®. The detailed process is shown in Figure 1. : Out of the 856 reviewed discharges during the project period, three prescriptions had pending Issues after 15:00 due to communication challenges with the prescribers because of the high turnover. Figure 2 illustrates the discharge rates before 16:00.

The discharge pharmacy started preparing medications 3 hours earlier (Figure 1). Accordingly, 100% of patients’ disposition was achieved by 16:00 instead of 19:00 before the new process. Additionally, sixteen pending discharges had their discharge medications proposed by clinical pharmacists and documented in Cerner®. They were ready for dispensing once discharge was confirmed with no prescribing errors. : The clinical pharmacy service within MSH enhanced the discharge process safety by ensuring a 100% review of the discharge prescriptions and more than 99% of the issues resolved before reaching the discharge pharmacy. Moreover, this process facilitated earlier patients’ disposition by about 3 hours. Further studies among HMC facilities are warranted.

Loading

Article metrics loading...

/content/journals/10.5339/jemtac.2022.qhc.32
2021-11-30
2022-09-28
Loading full text...

Full text loading...

/deliver/fulltext/jemtac/2022/1/jemtac.2022.qhc.32.html?itemId=/content/journals/10.5339/jemtac.2022.qhc.32&mimeType=html&fmt=ahah

References

  1. Patel H, Virapongse A, Baduashvili A, Devitt J, Barr R, Bookman K. Implementing a COVID-19 Discharge Pathway to Improve Patient Safety. American Journal of Medical Quality. 2021 Mar; 36:(2):84–89.
    [Google Scholar]
  2. Michaelson M, Walsh E, Bradley CP, McCague P, Owens R, Sahm LJ. Prescribing error at hospital discharge: a retrospective review of medication information in an Irish hospital. Irish Journal of Medical Science. 2017 Aug; 186:(3):795–800.
    [Google Scholar]
  3. Visacri MB, Figueiredo IV, Lima TM. Role of pharmacist during the COVID-19 pandemic: a scoping review. Research in social and administrative pharmacy. 2021 Jan 1; 17:(1):1799–806.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/jemtac.2022.qhc.32
Loading
/content/journals/10.5339/jemtac.2022.qhc.32
Loading

Data & Media loading...

  • Article Type: Conference Abstract
Keyword(s): Clinical PharmacyCOVID-19Discharge planearly discharge and Medication review

Most Cited This Month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error